Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Riggan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical & Translational Immunology|January 18, 2021
Arrested development: suppression of NK cell function in the tumor microenvironmentLuke Riggan, Siya Shah, Timothy E O'Sullivan
Trends in Immunology|September 11, 2019
True Detective: Unraveling Group 1 Innate Lymphocyte HeterogeneityLuke Riggan, Aharon G Freud, Timothy E O'Sullivan
STAR Protocols|December 30, 2020
CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune CellsAndrew D Hildreth, Luke Riggan, Timothy E O'Sullivan
Immunity|December 8, 2019
Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in HepatocytesTsukasa Nabekura, Luke Riggan, Andrew D Hildreth, et al.
Nature Immunology|March 15, 2022
The transcription factor Fli1 restricts the formation of memory precursor NK cells during viral infectionLuke Riggan, Feiyang Ma, Joey H Li, et al.
Cell Reports|May 21, 2020
CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Mature Primary Innate Immune CellsLuke Riggan, Andrew D Hildreth, Marion Rolot, et al.
Frontiers in Aging|August 8, 2022
Mifepristone Increases Life Span in Female <i>Drosophila</i> Without Detectable Antibacterial ActivityGary N Landis, Luke Riggan, Hans S Bell, et al.
Molecular Cancer Research : MCR|May 4, 2017
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155Michael D Nyquist, Alexandra Corella, John Burns, et al.
Frontiers in Oncology|January 11, 2021
Reciprocal Induction of MDM2 and MYCN in Neural and Neuroendocrine CancersHung N Tran, Hardeep P Singh, Wenxuan Guo, et al.
Blood|November 4, 2022
Lentiviral gene therapy for X-linked chronic granulomatous disease recapitulates endogenous CYBB regulation and expressionRyan L Wong, Sarah Sackey, Devin Brown, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical & Translational Immunology|January 18, 2021
Arrested development: suppression of NK cell function in the tumor microenvironmentLuke Riggan, Siya Shah, Timothy E O'Sullivan
Trends in Immunology|September 11, 2019
True Detective: Unraveling Group 1 Innate Lymphocyte HeterogeneityLuke Riggan, Aharon G Freud, Timothy E O'Sullivan
STAR Protocols|December 30, 2020
CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune CellsAndrew D Hildreth, Luke Riggan, Timothy E O'Sullivan
Immunity|December 8, 2019
Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in HepatocytesTsukasa Nabekura, Luke Riggan, Andrew D Hildreth, et al.
Nature Immunology|March 15, 2022
The transcription factor Fli1 restricts the formation of memory precursor NK cells during viral infectionLuke Riggan, Feiyang Ma, Joey H Li, et al.
Cell Reports|May 21, 2020
CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Mature Primary Innate Immune CellsLuke Riggan, Andrew D Hildreth, Marion Rolot, et al.
Frontiers in Aging|August 8, 2022
Mifepristone Increases Life Span in Female <i>Drosophila</i> Without Detectable Antibacterial ActivityGary N Landis, Luke Riggan, Hans S Bell, et al.
Molecular Cancer Research : MCR|May 4, 2017
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155Michael D Nyquist, Alexandra Corella, John Burns, et al.
Frontiers in Oncology|January 11, 2021
Reciprocal Induction of MDM2 and MYCN in Neural and Neuroendocrine CancersHung N Tran, Hardeep P Singh, Wenxuan Guo, et al.
Blood|November 4, 2022
Lentiviral gene therapy for X-linked chronic granulomatous disease recapitulates endogenous CYBB regulation and expressionRyan L Wong, Sarah Sackey, Devin Brown, et al.
Pageof 2